Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment
Celanese Announces Collaboration with Alessa Therapeutics for the Advancement of Oncology Treatments
Celanese Announces Hytrel® Price Increases
Celanese Corporation Reports Full Year 2022 and Fourth Quarter Earnings
Celanese and Mitsui & Co., Ltd. to Form Food Ingredients Joint Venture; Extend Existing Fairway Methanol LLC Joint Venture
Celanese Completes EVA Capacity Expansion at Acetyl Chain Facility in Edmonton
Celanese Announces a Research Agreement with Johns Hopkins University to Advance Sustained Ocular Drug Delivery to the Suprachoroidal Space
Celanese Corporation Declares Quarterly Dividend of $0.70 Per Share
Celanese Expanding Portfolio of Sustainable Products Across Acetyl Chain
Celanese to Hold Fourth Quarter Earnings Conference Call on February 24, 2023